Home · Stock · ZTS

ZTS Zoetis Inc

Which ETFs hold ZTS? Zoetis Inc is held by 2 funds tracked by ETFpeek.

Held by 2 funds todayData as of 31 Aug 2026
HealthcareDrug Manufacturers - Specialty & Generic
$73.08
-47.2% 1y
$68.7752-week range$148.30
Market cap
$28.8B
P/E
12.0
Dividend
2.90%
3-month
-2.6%
CEO
Ms. Kristin C. Peck
Revenue · last 4 qtrs (-0.2% YoY)

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.

Provider

Currently Held By

VANGUARD
VOO
Weight in fund0.05%
Shares held11,137,236
Market value$858.7M
View fund →
SMARTSHARES
USF
Smart US 500 ETF
via VOO
Weight in fund0.05%
Shares held—
Market value$612K NZD
View fund →
Not held by the selected provider.
last 90 days
No notable insider activity in the last 90 days. Show all 2 trades
Net flow (90d):−$19K (1 without value)·1 BUY / 1 SELL·showing all trades
DatePersonActionPlanSharesValueScore i
30 Sep 2026
Julie Fuller
Executive VP, Chief Human Resources Officer & Global Operations
BUYOption Exercise799—0
30 Sep 2026
Julie Fuller
Executive VP, Chief Human Resources Officer & Global Operations
SELLVested (RSU)274$19K0
Data: Finnhub (SEC Form 4 filings) · Score: ETFpeek heuristic
0 trades
DateFundDirectionShares Changed% Δ ETF i% Δ Position i
No trades recorded yet.
No trade history for SmartShares funds — their underlying ETFs are passive index trackers, so day-to-day rebalancing is minimal.

More stocks in these funds